Carbonate ion

Generic Name: Carbonate ion

Drug Type: Small Molecule

Chemical Formula: CO_₃

CAS Number: 3812-32-6

Unique Ingredient Identifier: 7UJQ5OPE7D

Clinical Trials

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects

Phase 1

Not yet recruiting

Conditions: Pharmacokinetics
Neurology

Interventions: Drug: AL001
Drug: Lithium Carbonate Capsule

First Posted Date: 2025-04-10

Last Posted Date: 2025-04-10

Lead Sponsor: Alzamend Neuro, Inc.

Target Recruit Count: 6

Registration Number: NCT06921590

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment

Phase 2

Recruiting

Conditions: Cornelia De Lange Syndrome

Interventions: Drug: Lithium Carbonate Capsule

First Posted Date: 2025-01-23

Last Posted Date: 2025-01-28

Lead Sponsor: University of Milan

Target Recruit Count: 34

Registration Number: NCT06789783

Locations: 🇮🇹
University of Milan, Milan, MI, Italy

A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

Phase 2

Completed

Conditions: Chronic Kidney Disease Requiring Chronic Dialysis

Interventions: Drug: Oxylanthanum Carbonate

First Posted Date: 2024-01-23

Last Posted Date: 2024-06-24

Lead Sponsor: Unicycive Therapeutics, Inc

Target Recruit Count: 106

Registration Number: NCT06218290

Locations: 🇺🇸
Clinical Advancement Center, PLLC, San Antonio, Texas, United States
🇺🇸
US Renal Care, San Antonio, Texas, United States

Effect of Lithium Carbonate on Postoperative Sleep and Cognitive Function in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

Phase 4

Recruiting

Conditions: Heart Valve Surgery

Interventions: Drug: Lithium Carbonate 250 MG Oral Tablet
Drug: Calcium Carbonate 500 MG Oral Tablet

First Posted Date: 2022-10-25

Last Posted Date: 2023-07-18

Lead Sponsor: China Medical University, China

Target Recruit Count: 62

Registration Number: NCT05593627

Locations: 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China

Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression

Phase 4

Conditions: Depressive Disorder

Interventions: Drug: Lithium Carbonate Pill
Drug: Lithium carbonate + perospirone hydrochloride
Drug: Perospirone hydrochloride tablets

First Posted Date: 2021-04-01

Last Posted Date: 2021-04-01

Lead Sponsor: Shanghai Mental Health Center

Target Recruit Count: 189

Registration Number: NCT04826510

Locations: 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Phase 4

Completed

Conditions: Smallpox

Interventions: Drug: Tecovirimat
Drug: sevelamer carbonate oral tablet
Drug: sucroferric oxyhydroxide chewable tablet
Drug: calcium acetate oral tablet
Drug: Lanthanum Carbonate Chewable Tablet

First Posted Date: 2020-07-24

Last Posted Date: 2024-12-27

Lead Sponsor: SIGA Technologies

Target Recruit Count: 44

Registration Number: NCT04485039

Locations: 🇺🇸
PPD Phase I Clinic, Austin, Texas, United States

Effect of Lithium Carbonate on Postoperative Sleep in Patients Undergoing Videoassisted Thoracic Surgery

Phase 4

Completed

Conditions: Sleep Deprivation

Interventions: Drug: Calcium Carbonate 500 MG
Drug: Lithium Carbonate 250 MG

First Posted Date: 2020-07-21

Last Posted Date: 2022-02-04

Lead Sponsor: China Medical University, China

Target Recruit Count: 51

Registration Number: NCT04479566

Locations: 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China

Healthy Combine Study

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Nicotinamide
Drug: Nicotinamide Placebo
Drug: Lanthanum Carbonate
Drug: Lanthanum Carbonate Placebo

First Posted Date: 2017-05-02

Last Posted Date: 2024-02-23

Lead Sponsor: Northwestern University

Target Recruit Count: 39

Registration Number: NCT03136705

Locations: 🇺🇸
Center for Translational Metabolism and Health (CTMH), Northwestern University, Chicago, Illinois, United States

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

Phase 1

Completed

Conditions: Healthy Subjects

Interventions: Drug: ASP1517
Drug: Lanthanum carbonate hydrate

First Posted Date: 2016-11-02

Last Posted Date: 2017-01-25

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 18

Registration Number: NCT02952040

Locations: 🇯🇵
Site JP00001, Tokyo, Japan

Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients

Phase 3

Completed

Conditions: Hyperphosphatemia

Interventions: Drug: Lanthanum Carbonate (BAY77-1931)

First Posted Date: 2012-01-26

Last Posted Date: 2016-03-14

Lead Sponsor: Bayer

Target Recruit Count: 43

Registration Number: NCT01518387

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy